Lentiviral vectors end user license agreement

Discover Vectalys’ license agreement for lentiviral vectors and non-integrating lentiviral particles.

Products based on integrative lentiviral vectors

All lentiviral vectors generated by Vectalys are subject to Vectalys end-user limits.

  • Vectalys’ lentiviral vectors contain Lentikat technology owned by Life Technologies Corp. (Now Thermofisher). Thermofisher’s End-User limits apply to purchasers based in the US, Canada, Australia and Japan.
  • Vectalys’ lentiviral vectors contain a cPPT Element owned by Institut Pasteur (France). Institut Pasteur’s End-User limits apply to all purchasers of Vectalys’ integrative lentiviral vectors, whatever the purchaser’s localization.
  • Vectalys offers to generate products based on integrative lentiviral vectors containing Tetracycline controllable expression systems owned by TET Systems (Germany), only to Qualified Buyers having a license agreement with TET Systems, and to Academics.
  • Vectalys offers to generate products based on integrative lentiviral vectors containing Zsgreen and/or mCherry fluorescent proteins, owned by Clontech Laboratories Inc. Clontech’s End-User limits apply to all purchasers of Vectalys’ integrative lentiviral vectors containing these fluorescent proteins, whatever purchaser’s localization.
  • Vectalys offers to generate integrative lentiviral vectors containing TurboGFP, AcGFP2, TurboRFP, mKate and tagBFP, owned by Evrogen JSC. Evrogen’s End-User limits apply to purchasers of Vectalys’ integrative lentiviral vectors containing these fluorescent proteins , based in the US, Europe and Russia.

Products based on RNA-based lentiviral particles (RLP or LentiFlash)

All RLP generated by Vectalys are subject to Vectalys End-User limits.

  • Vectalys offers to generate products based on integrative lentiviral vectors containing Zsgreen and/or mCherry fluorescent proteins, owned by Clontech Laboratories Inc. Clontech’s End-User limits apply to all purchasers of Vectalys’ integrative lentiviral vectors containing these fluorescent proteins, whatever purchaser’s localization.
  • Vectalys offers to generate integrative lentiviral vectors containing TurboGFP, AcGFP2, TurboRFP, mKate and tagBFP, owned by Evrogen JSC (Russia). Evrogen’s End-User limits apply to purchasers of Vectalys’ integrative lentiviral vectors containing these fluorescent proteins , based in the US, Europe and Russia.
Resources
Resources